Obstetrics & gynaecology
Why is there a shortage of estrogen patches in Australia again?
Since 2020 or so, there have been recurring national shortages of estrogen transdermal patches in Australia.
Mar 6, 2024
0
0
News tagged with therapeutic benefit
Medications
Early trial results show reduced frequency and intensity of migraine attacks after single dose of psilocybin
Psilocybin, the active ingredient in psychedelic mushrooms, shows promise for the transitional treatment of episodic migraines in early clinical trials, according to a review from Yale School of Medicine's Emmanuelle Schindler, ...
Aug 9, 2023
0
4
Health
Study finds non-LSD hallucinogen use on the rise among young adults
Young adults ages 19 to 30 nearly doubled their past 12-month use of non-LSD hallucinogens in the United States from 2018 to 2021, according to a study by the University of Michigan and Columbia University.
Jun 8, 2023
0
7
Medications
Study: Over half of top selling Medicare drugs have low added therapeutic benefit
Brand-name drugs cost two to three times more in the U.S. than in other countries, but many of the top-selling brand name drugs may provide little added therapeutic benefit. A new study led by researchers at Brigham and Women's ...
Apr 18, 2023
0
133
Medications
Australia to legalise MDMA and magic mushrooms for medical use
Australia's drugs watchdog on Friday announced that psychedelic substances MDMA and psilocybin—more commonly known as ecstasy and magic mushrooms—will soon be used in the treatment of depression and post-traumatic stress.
Feb 3, 2023
0
24
Diabetes
Hormone infusion improves pancreatic insulin production in cystic fibrosis patients with or at risk for diabetes
Cystic fibrosis is well-known for attacking the lungs through thick blockages of mucus, but those with the condition often also develop diabetes because of the way cystic fibrosis can affect the pancreas. Since diabetes has ...
Jul 21, 2022
0
5
Medications
Controversial Alzheimer's drug should not be approved out of desperation, warn Aussie experts
Aducanumab, a controversial Alzheimer's disease medication with "questionable efficacy," is under review by the Therapeutic Goods Administration, but authors of a Perspective published today by the Medical Journal of Australia ...
Feb 21, 2022
0
13
Medical research
Study uncovers a new understanding of how mesenchymal stromal cells benefit patients in cell therapy
The therapeutic benefit to patients receiving mesenchymal stromal cell (MSC) therapy is not because the injected cells remain viable, but because of cell death, researchers at the Monash Biomedicine Discovery Institute (BDI) ...
Nov 11, 2021
0
65
Psychology & Psychiatry
Psychedelic experience may not be required for psilocybin's antidepressant-like benefits
University of Maryland School of Medicine (UMSOM) researchers have shown that psilocybin—the active chemical in 'magic mushrooms'— still works its antidepressant-like actions, at least in mice, even when the psychedelic ...
Apr 13, 2021
0
9
Neuroscience
Molecular control of neurotransmitter linked to autism described
Many neurodevelopmental disorders such as epilepsy, schizophrenia, and autism have been linked to disruption of the key neurotransmitter GABA, but the underlying causes of the disruptions have been difficult to pinpoint. ...
Oct 17, 2019
0
334
